News & Analysis as of

White Papers Regulatory Oversight

Arnall Golden Gregory LLP

Welcome to the Machine: FDA Issues White Paper on AI and Medical Products

For music aficionados, many would agree that the rock band, Pink Floyd, was ahead of its time. “Welcome to the Machine,” from the 1975 album Wish You Were Here, was one of those transformative songs for one of this Bulletin’s...more

Goodwin

Overview of the UK Government’s AI White Paper

Goodwin on

The Department for Science, Innovation and Technology published a white paper on 29 March 2023 titled "AI Regulation: A Pro-Innovation Approach", which sets out the UK Government’s proposals to regulate artificial...more

Morgan Lewis

New Independent English Football Regulator: A Potential Game-Changer?

Morgan Lewis on

Following an English football fan–led review, the UK government recently proposed numerous changes for the game’s clubs, key among them being the appointment of an independent regulator with oversight for many areas of fan...more

Latham & Watkins LLP

The UK’s AI Strategy: Where Are We Now?

Latham & Watkins LLP on

Last year, the UK Department of Digital, Culture, Media and Sport (DCMS) published its 10- year National AI Strategy for the regulation and promotion of artificial intelligence (AI) in the UK (Report). DCMS seeks to build...more

Latham & Watkins LLP

Hong Kong Fintech Week 2020: 3 Key Policy Initiatives of the HKMA

Latham & Watkins LLP on

The HKMA introduces a new data sharing initiative, reported on the central bank digital currency initiative, and outlined regtech plans. The fifth annual Hong Kong Fintech Week conference kicked off with speeches and panels...more

White & Case LLP

Regulation of Artificial Intelligence in Europe and Japan

White & Case LLP on

Enterprises around the world are rapidly incorporating artificial intelligence (AI) into existing and new products and processes. This effort is not just to improve such offerings and services, but to achieve a qualitatively...more

McDermott Will & Emery

Reviewing Key Principles from FDA's Artificial Intelligence White Paper

McDermott Will & Emery on

In April 2019, the US Food and Drug Administration (FDA) issued a white paper, “Proposed Regulatory Framework for Modifications to Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device,”...more

Akin Gump Strauss Hauer & Feld LLP

FDA’s AI White Paper: To Be or Not to Be, That is the Question

• FDA has released a white paper outlining a potential regulatory framework for software as a medical device (SaMD) that leverages artificial intelligence (AI) or machine learning (ML). • The white paper distinguishes three...more

8 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide